INFUSOMAT SPACE INFUSION PUMP (Registro Anvisa: 80136990568). 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Laboratórios B. Braun S.A.; B. Braun Melsungen AG. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1050
  • 날짜
    2011-02-25
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    During the installation of the equipment in the pump, if the user ignores the instructions for use and fails to insert the safety clamp correctly, the equipment will issue an alert (yellow light) signaling the installation error. If the user ignores the alert signal and proceeds by closing the front door of the infusion pump, a second warning signal will be displayed on the display "Infusion Line Change - Keep the Closed Drops Regulator!". If, however, the user continues to attempt to program infusion parameters, the device will display the message "Open Port and Enter Line (Equipment) or Press 'C' to Enter Parameters". If the user insists on entering parameters, this sequence will be accepted by the equipment, and then, if the roller gripper is opened, gravity-free flow may occur to the patient. If this sequence of events occurs, the drip will be visible in the drip chamber and the operator will still have the opportunity to close the roller clamp manually and correct the clamp insert against free flow. According to the product registration holder, the instructions for correct use of the product are affixed to the front door of the product and are passed on to the training provided to users. The company informed that such information (instructions for use) will be reiterated through letters to customers. Anvisa's Technovigilance Unit is monitoring this case.
  • 원인
    Possibility of occurrence of free flow (by gravity) for the patient.
  • 조치
    Users of the product should follow the instructions for inserting the safety clip, which are affixed to the front door of the product. The health facility is advised to advise its employees of the problem in question, guiding them to follow the handling instructions correctly in order to avoid the occurrence of the problem mentioned in this alert. According to the product registration holder (Laboratorios B. Braun SA), the manufacturer (B. Braun Melsungen AG) has already initiated actions in order to implement a more efficient and safe infusion line occlusion system for infusion pumps INFUSOMAT. According to the registry holder, such product update will occur in the next software release ("J" version).

Manufacturer